HALIODX

Summary

HalioDx is an immuno-oncology diagnostic company providing oncologists and Biopharma with first-in-class immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 224 M

Avg. Deal Size£ 224 M

Market Context